This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Identifying a structural brain lesion on MRI has important implications in epilepsy and is the most important factor that correlates with seizure freedom after surgery in patients with drug-resistant focal onset epilepsy. However, at conventional magnetic field strengths (1.5 and 3T), only approximately 60%–85% of MRI examinations reveal such lesions. Over the last decade, studies have demonstrated the added value of 7T MRI in patients with and without known epileptogenic lesions from 1.5 and/or 3T. However, translation of 7T MRI to clinical practice is still challenging, particularly in centers new to 7T, and there is a need for practical recommendations on targeted use of 7T MRI in the clinical management of patients with epilepsy. The 7T Epilepsy Task Force—an international group representing 21 7T MRI centers with experience from scanning over 2,000 patients with epilepsy—would hereby like to share its experience with the neurology community regarding the appropriate clinical indications, patient selection and preparation, acquisition protocols and setup, technical challenges, and radiologic guidelines for 7T MRI in patients with epilepsy. This article mainly addresses structural imaging; in addition, it presents multiple nonstructural MRI techniques that benefit from 7T and hold promise as future directions in epilepsy. Answering to the increased availability of 7T MRI as an approved tool for diagnostic purposes, this article aims to provide guidance on clinical 7T MRI epilepsy management by giving recommendations on referral, suitable 7T MRI protocols, and image interpretation.
Glossary
- DNET=
- dysembryoplastic neuroepithelial tumor;
- DRFE=
- drug-resistant focal epilepsy;
- FCD=
- focal cortical dysplasia;
- FLAIR=
- fluid-attenuated inversion recovery;
- FWMS=
- fluid and white matter suppressed;
- GRE=
- gradient-recalled echo;
- HS=
- hippocampal sclerosis;
- LEAT=
- long-term epilepsy-associated tumor;
- MCD=
- malformations of cortical development;
- MPRAGE=
- magnetization-prepared rapid acquisition gradient echo;
- MRS=
- magnetic resonance spectroscopy;
- RF=
- radiofrequency;
- SNR=
- signal-to-noise ratio;
- SWAN=
- susceptibility-weighted angiography;
- SWI=
- susceptibility-weighted imaging;
- TLE=
- temporal lobe epilepsy;
- TSE=
- turbo spin echo;
- UHF=
- ultrahigh field
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received June 2, 2020.
- Accepted in final form October 29, 2020.
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- Glossary
- Clinical Indications, Patient Preparation, and Safety
- Acquisition Protocol and Recommended Setup
- Radiologic Considerations and Visual Assessment
- Technical Issues Relevant For Clinical Practice
- Future Directions and Concluding Remarks
- Study Funding
- Disclosures
- Appendix Authors
- Footnotes
- References
- Figures & Data
- Info & Disclosures
